Novitas Announces Future Non-Coverage of Opko's 4Kscore Prostate Cancer Test

Feb 01, 2019

|

NEW YORK (360Dx) – Opko Health announced that Medicare administrator Novitas Solutions has issued a notice of future non-coverage determination for the company's 4Kscore prostate cancer test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Novitas Announces Future Non-Coverage of Opko's 4Kscore Prostate Cancer Test

To read the full story....

Breaking News

Qiagen Reports 26 Percent Q3 Revenue Growth; Ups Full-Year Guidance

Inspirata, Flagship Bio Enter Digital Pathology Pact

BARDA Awards Additional $4M to First Light Diagnostics for Rapid Anthrax Test

Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent

NeoGenomics Q3 Revenues Rise 20 Percent

FDA Reissues EUA for Broad Institute Coronavirus Test, Authorizes Immunoassay From Celltrion

Featured White Papers

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

What's Popular?

Israeli Diagnostics Firm NanoSynex Aiming for European Market Entry for AMR Test by 2023

Sponsorships